AbbVie's (ABBV) Allergan Submits NDA to FDA for AGN-190584 to Treat Presbyopia

Go back to AbbVie's (ABBV) Allergan Submits NDA to FDA for AGN-190584 to Treat Presbyopia
AbbVie (NYSE: ABBV) Delayed: 115.75 -0.33 (0.28%)
Previous Close $116.08    52 Week High $68.12 
Open $116.38    52 Week Low $50.71 
Day High $116.93    P/E 25.11 
Day Low $114.96    EPS $4.61 
Volume 6,808,128